Figure 2
From: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy

Symptom occurrence with (A) initial escalation day, (B) dose escalations and (C) home dosing during OIT to multiple foods.
From: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Symptom occurrence with (A) initial escalation day, (B) dose escalations and (C) home dosing during OIT to multiple foods.